Low doses of aspirin can boost fertility
Forget
expensive treatments and drugs, even the ubiquitous aspirin could increase a
woman's fertility, research finds.
Low doses of the drug could improve the chances of conception and of having a live birth. The reason for this could be that aspirin increases blood flow to the womb, the researchers said.
However, contrary to popular belief, taking the drug does not prevent miscarriage.
Researchers at the National Institutes of Health randomly assigned more than 1,000 women with a history of pregnancy loss either a low dose of aspirin daily or a placebo.
They then followed them for six months while they tried to conceive.
The researchers found there was no difference in the pregnancy loss rates between the two groups. However, they found that women who had experienced a single, recent pregnancy loss had an increased rate of pregnancy and live birth while taking a daily aspirin tablet.
These women were classed as those who had lost a baby before four and a half months gestation within the past year.
Among these women, 78 per cent became pregnant during the study, compared to 66 per cent of those who took the placebo, said the study published in the journal The Lancet.
05.04.2014
Weight loss can save people at diabetes risk
Researchers
have said that losing weight helped people, who were at risk of diabetes,
decreases their chances of dying from cardiovascular disease.
Professor Guangwei Li of the China-Japan Friendship Hospital, Beijing, China, and colleagues, presented the results from the 23-year follow up of the Da Qing Diabetes Prevention Study, a randomized controlled trial, which showed that people in China with impaired glucose tolerance randomized to lifestyle interventions had significantly reduced death rates from cardiovascular disease and all-causes, compared to those patients randomized to the control arm.
The investigators enrolled 438 patients assigned to intervention clinics, and 138 patients were assigned to control clinics. The study intervention lasted for 6 years, and patients were then followed up for 23 years.
At the end of the follow up period, cumulative incidence of death from cardiovascular disease was 11.9 per cent in the lifestyle intervention group, versus 19.6 per cent in the control group, and death from all causes was 28.1 per cent in the lifestyle group versus 38.4 per cent in the control group. The difference between groups for both outcomes was statistically significant.
The new research has been published in The Lancet Diabetes and Endocrinology journal.
05.04.2014
When
someone tells you it can’t be done, it is a reflection of their limitations,
not yours
No comments:
Post a Comment